![Steven Stein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Stein
Teknisk/Vetenskaplig/F&U Direktör på
INCYTE CORPORATION
Förmögenhet: 8 M $ per 2026-05-31
Profil
Steven H.
Stein is Chief Medical Officer & Executive Vice President at Incyte Corp.
since 2016.
Dr. Stein is Assistant Professor at the University of Pennsylvania.
Dr. Stein is Venture Advisor at Israel Biotech Fund.
Former roles include Independent Director at Kura Oncology, Inc. from 2017 to 2023, Director at Repare Therapeutics, Inc. from 2024 to 2026, Independent Director at Theseus Pharmaceuticals, Inc. from 2022 to 2024, SVP-US Clinical Development & Medical Affairs at Novartis Oncology, Inc. from 2011 to 2015, Senior VP-US Clinical Development & Medical Affair at Novartis Pharmaceuticals Corp.
from 2011 to 2015, and Vice President-Global Oncology at GlaxoSmithKline (New Jersey) from 2004 to 2011.
Education includes a doctorate from the University of the Witwatersrand conferred in 1990.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
INCYTE CORPORATION 0,04 % | 2026-05-06 | 78 327 ( 0,04 % ) | 8 M $ | 2026-05-31 |
Aktiva positioner av Steven Stein
| Företag | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2015-03-02 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Konsult / Rådgivare | - |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Tidigare kända positioner av Steven Stein
| Företag | Position | Slut |
|---|---|---|
| REPARE THERAPEUTICS INC. | Direktör/Styrelseledamot | 2026-01-28 |
| THESEUS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2024-02-14 |
| KURA ONCOLOGY, INC. | Direktör/Styrelseledamot | 2023-05-01 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Företagsledare/Principal | 2015-02-01 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Företagsledare/Principal | 2015-02-01 |
Steven Steins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
60
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
